JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3026
PUT
Fidelity National Information Services
FIS
$16.7B
| $6.46M | ﹤0.01% |
80,000
| – | – |
2024 Q3
1 quarter
|
|
|
NUVL
3027
DELISTED
Nuvalent
NUVL
| $6.46M | ﹤0.01% |
82,527
+47,818
| +138% | +$4.47M |
2021 Q3
13 quarters
|
|
|
SHOE
3028
Shoe Station Group
SHOE
$342M
| $6.44M | ﹤0.01% |
194,627
+132,844
| +215% | +$4.81M |
2016 Q4
32 quarters
|
|
3029
PUT
Logitech
LOGI
$14.9B
| $6.43M | ﹤0.01% |
78,100
| – | – |
2021 Q3
13 quarters
|
|
3030
CALL
HCA Healthcare
HCA
$92.4B
| $6.42M | ﹤0.01% |
21,400
| – | – |
2021 Q2
14 quarters
|
|
3031
Avantis International Equity ETF
AVDE
$18.8B
| $6.41M | ﹤0.01% |
104,368
+7,864
| +8% | +$503K |
2022 Q3
9 quarters
|
|
3032
BlackRock ETF Trust II iShares AAA CLO Active ETF
CLOA
$2.34B
| $6.4M | ﹤0.01% |
123,704
-14,115
| -10% | -$731K |
2024 Q2
2 quarters
|
|
3033
Gentherm
THRM
$962M
| $6.4M | ﹤0.01% |
160,176
+92,345
| +136% | +$3.87M |
2014 Q3
41 quarters
|
|
|
ACH
3034
Accendra Health
ACH
$38.9M
| $6.38M | ﹤0.01% |
488,497
+111,667
| +30% | +$1.49M |
2013 Q2
46 quarters
|
|
3035
Dutch Bros
BROS
$5.33B
| $6.38M | ﹤0.01% |
121,801
-246,952
| -67% | -$10.9M |
2021 Q4
12 quarters
|
|
|
EVRI
3036
DELISTED
Everi Holdings
EVRI
| $6.37M | ﹤0.01% |
471,636
+22,849
| +5% | +$305K |
2017 Q1
31 quarters
|
|
3037
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.53B
| $6.37M | ﹤0.01% |
349,679
-33,165
| -9% | -$606K |
2021 Q2
14 quarters
|
|
3038
PUT
Cognizant
CTSH
$26.4B
| $6.37M | ﹤0.01% |
82,800
| – | – |
2024 Q1
3 quarters
|
|
3039
Alphatec Holdings
ATEC
$1.55B
| $6.36M | ﹤0.01% |
692,368
-3,320,470
| -83% | -$26.5M |
2019 Q2
22 quarters
|
|
|
SUPV
3040
Grupo Supervielle
SUPV
$601M
| $6.35M | ﹤0.01% |
420,286
+45,771
| +12% | +$488K |
2023 Q4
4 quarters
|
|
3041
CALL
Align Technology
ALGN
$10.2B
| $6.34M | ﹤0.01% |
30,400
| – | – |
2024 Q1
3 quarters
|
|
|
JPUS
3042
JPMorgan Diversified Return US Equity ETF
JPUS
$453M
| $6.34M | ﹤0.01% |
55,523
+342
| +0.6% | +$40.8K |
2015 Q4
36 quarters
|
|
3043
Joby Aviation
JOBY
$5.93B
| $6.33M | ﹤0.01% |
779,095
+439,436
| +129% | +$2.91M |
2021 Q3
13 quarters
|
|
3044
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.16B
| $6.33M | ﹤0.01% |
262,817
+6,099
| +2% | +$147K |
2020 Q1
19 quarters
|
|
3045
Spectrum Brands
SPB
$1.8B
| $6.33M | ﹤0.01% |
74,868
-2,495
| -3% | -$226K |
2013 Q2
46 quarters
|
|
3046
Community Trust Bancorp
CTBI
$1.38B
| $6.32M | ﹤0.01% |
119,197
+23,964
| +25% | +$1.31M |
2013 Q2
46 quarters
|
|
3047
Nkarta
NKTX
$185M
| $6.32M | ﹤0.01% |
2,537,922
+1,474,560
| +139% | +$4.55M |
2020 Q3
17 quarters
|
|
3048
Sera Prognostics
SERA
$82.4M
| $6.32M | ﹤0.01% |
775,871
-108,996
| -12% | -$801K |
2021 Q3
13 quarters
|
|
3049
PUT
Unity
U
$19.2B
| $6.31M | ﹤0.01% |
280,900
+215,000
| +326% | +$4.78M |
2024 Q1
3 quarters
|
|
3050
ZTO Express
ZTO
$14.6B
| $6.3M | ﹤0.01% |
322,060
-621,420
| -66% | -$13.6M |
2016 Q4
32 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.